Arcadia Biosciences Raises $2.1 Million Through Exercise of Preferred Investment Options
I'm PortAI, I can summarize articles.
Arcadia Biosciences Inc. has raised $2.1 million by exercising preferred investment options, allowing the purchase of 808,595 shares of common stock at a reduced price of $2.575 per share. Additionally, the company will issue new preferred investment options for 1,617,190 shares at $2.325 per share. The proceeds will be used for working capital and general corporate purposes.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments